Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
Year: 2018
Dis-Ad-vantaged viruses: Comparing diverse Adenoviruses to uncover different interactions with cellular DNA repair proteins
Improved vaccine candidates for measles virus by reverse genetics
Mysterious spot in the large Melbourenvirus particle
Are picobirnaviruses actually RNA bacteriophage rather than eukaryotic viruses?
The roles of five conserved lentiviral RNA structures in HIV-1 replication
Development of a novel equine influenza virus live-attenuated vaccine
